DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

Cepheid (NASDAQ: CPHD)

54.30 0.35 (0.65%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CPHD $54.30 0.65%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $53.94
Previous Close $53.95
Daily Range $53.61 - $54.69
52-Week Range $36.94 - $56.47
Market Cap $3.8B
P/E Ratio -99.91
Dividend (Yield) $0.00 (0.0%)
Volume 752,515
Average Daily Volume 585,171
Current FY EPS -$0.52

Sector

Technology

Industry

Electronics

Cepheid (CPHD) Description

A molecular diagnostics company that develops, manufactures, and markets fully-integrated systems for genetic analysis in the Clinical Molecular Diagnostic, Industrial and Biothreat markets. Website: http://www.cepheid.com/

News & Commentary Rss Feed

Why Cepheid Stock Nosedived

Molecular diagnostic company Cepheid may need to do some internal analyzing after its full-year outlook failed to excite investors.

Benzinga's Top Upgrades

Top Analyst Upgrades and Downgrades: AMD, Ally, FedEx, Halliburton, Intel, Tenet, Tyco and More

First Week of CPHD June 2015 Options Trading

UPDATE: Citigroup Reiterates On Cepheid Following Positive Data

Cepheid Wins FDA Clearance for Xpert Norovirus Test - Analyst Blog

Cepheid Wins FDA Clearance for Xpert Norovirus Test - Analyst Blog

Cepheid Receives FDA Clearance For Xpert Norovirus, The First On-Demand Molecular Test For Detection

Cepheid Receives FDA Clearance For Xpert Norovirus, The First On-Demand Molecular Test For Detection of Norovirus

Cepheid Gets FDA Clearance for Xpert Flu/RSV XC Test - Analyst Blog

Cepheid Receives FDA Clearance For Xpert Flu/RSV XC

Cepheid Shines in Global Market, Raises Revenue Outlook - Analyst Blog

Health Care Sector Update for 11/13/2014: CPHD, CNC, AZN

See More CPHD News...

CPHD's Top Competitors

CPHD $54.30 (0.65%)
Current stock: CPHD
GILD $108.45 (2.76%)
Current stock: GILD
CELG $117.18 (0.60%)
Current stock: CELG
AMGN $170.17 (1.00%)
Current stock: AMGN